Recurrence-free and overall survival among elderly stage III colon cancer patients treated with CAPOX or capecitabine monotherapy

F. N. van Erning*, M. L. G. Janssen-Heijnen, G. J. Creemers, J. F. M. Pruijt, H. A. A. M. Maas, V. E. P. P. Lemmens

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)224-233
Number of pages10
JournalInternational Journal of Cancer
Volume140
Issue number1
DOIs
Publication statusPublished - Jan 2017

Keywords

  • adjuvant chemotherapy
  • capecitabine
  • colon cancer
  • elderly
  • overall survival
  • oxaliplatin
  • recurrence-free survival
  • SURGICAL ADJUVANT CHEMOTHERAPY
  • WEEKLY BOLUS FLUOROURACIL
  • COLORECTAL-CANCER
  • NSABP C-07
  • CONTROLLED-TRIALS
  • PLUS OXALIPLATIN
  • POOLED ANALYSIS
  • THERAPY
  • LEUCOVORIN
  • SAFETY

Cite this